NIH and Partners to Launch HIV Vaccine Efficacy Trial in the Americas and Europe | HIV.gov

NIH and Partners to Launch HIV Vaccine Efficacy Trial in the Americas and Europe | HIV.gov

NIH and Partners to Launch HIV Vaccine Efficacy Trial in the Americas and Europe

Today, NIH announced plans to conduct a Phase 3 HIV vaccine efficacy trial at multiple clinical research sites in North America, South America, and Europe. Learn about the details of the study...

LEARN MORE